Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Oya Alpar

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Drug Targeting|June 19, 2004
Strategies for vaccine deliveryH Oya Alpar
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2006
Development and characterisation of chitosan nanoparticles for siRNA deliveryHaliza Katas, H Oya Alpar
Journal of Drug Targeting|June 21, 2002
The development of polyplex-based DNA vaccinesKenneth Alan Howard, H Oya Alpar
Critical Reviews in Therapeutic Drug Carrier Systems|March 29, 2003
Current status of DNA vaccines and their route of administrationH Oya Alpar, Vincent W Bramwell
Advanced Drug Delivery Reviews|June 7, 2005
New frontiers in vaccines for emerging pathogensH Oya Alpar, Robert N Brey
International Journal of Pharmaceutics|June 23, 2009
An investigation into the combination of low frequency ultrasound and liposomes on skin permeabilityAfendi Dahlan, H Oya Alpar, Sudaxshina Murdan
International Journal of Pharmaceutics|November 18, 2008
Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA deliveryHaliza Katas, Erdal Cevher, H Oya Alpar
Expert Opinion on Drug Delivery|November 22, 2005
Strategies for DNA vaccine deliveryH Oya Alpar, Irene Papanicolaou, Vincent W Bramwell
International Journal of Pharmaceutics|December 9, 2008
Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticlesMan Tsuey Tse, Chris Blatchford, H Oya Alpar
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Biolistic transfection of human embryonic kidney (HEK) 293 cellsXiongwei Li, Masaki Uchida, H Oya Alpar, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Drug Targeting|June 19, 2004
Strategies for vaccine deliveryH Oya Alpar
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2006
Development and characterisation of chitosan nanoparticles for siRNA deliveryHaliza Katas, H Oya Alpar
Journal of Drug Targeting|June 21, 2002
The development of polyplex-based DNA vaccinesKenneth Alan Howard, H Oya Alpar
Critical Reviews in Therapeutic Drug Carrier Systems|March 29, 2003
Current status of DNA vaccines and their route of administrationH Oya Alpar, Vincent W Bramwell
Advanced Drug Delivery Reviews|June 7, 2005
New frontiers in vaccines for emerging pathogensH Oya Alpar, Robert N Brey
International Journal of Pharmaceutics|June 23, 2009
An investigation into the combination of low frequency ultrasound and liposomes on skin permeabilityAfendi Dahlan, H Oya Alpar, Sudaxshina Murdan
International Journal of Pharmaceutics|November 18, 2008
Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA deliveryHaliza Katas, Erdal Cevher, H Oya Alpar
Expert Opinion on Drug Delivery|November 22, 2005
Strategies for DNA vaccine deliveryH Oya Alpar, Irene Papanicolaou, Vincent W Bramwell
International Journal of Pharmaceutics|December 9, 2008
Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticlesMan Tsuey Tse, Chris Blatchford, H Oya Alpar
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Biolistic transfection of human embryonic kidney (HEK) 293 cellsXiongwei Li, Masaki Uchida, H Oya Alpar, et al.
Pageof 3